| Financial Year |
March 31 2023 |
| Monetary Funds |
300,654,317.75 |
| Held-for-trading Financial Assets |
90,950,577.76 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,009,144,582.14 |
| Advances to Suppliers |
8,851,380.39 |
| Other Receivables |
21,200,692.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
346,191,705.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,161,014.25 |
| Other Current Assets |
42,611,523.87 |
| Total Current Assets |
1,828,977,877.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,659,334.97 |
| Investment Properties |
-- |
| Fixed Assetes |
91,648,771.92 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,742,467.87 |
| R&D expenses |
38,114,855.89 |
| Goodwill |
51,158,121.49 |
| Long-Term Deferred and Prepaid Expenses |
3,825,263.13 |
| Deferred Income Tax Assets |
31,412,908.16 |
| Other Non-Current Assets |
5,150,000.00 |
| Sub-Total of Non-Current Assets |
356,733,650.79 |
| Total Assets |
2,185,711,528.43 |
| Short-Term Loans |
280,835,379.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,707,795.00 |
| Accounts Payable |
5,940,165.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
75,366,626.08 |
| Taxes Payable |
30,246,358.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,445,280.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,893,198.11 |
| Other Current Liabilities |
1,556,474.04 |
| Sub-Total of Current Liabilities |
460,837,055.17 |
| Long-term Loans |
14,976,710.91 |
| Bonds Payable |
297,625,253.94 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,889,555.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
331,323,169.64 |
| Total Liabilities |
792,160,224.81 |
| Paid-In Capital(Or Share Stock) |
238,723,764.00 |
| Capital Surplus |
501,508,009.49 |
| Surplus Reserve |
37,892,456.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
313,414,861.26 |
| Minority Stockholder's Interest |
113,692,408.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,279,858,895.38 |
| Owner's Equity（Stockholder's Equity） |
1,393,551,303.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,185,711,528.43 |
